Open Access

Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules

  • Authors:
    • Hyun Ah Park
    • Ok‑Kyoung Kwon
    • Hyung Won Ryu
    • Jae‑Hong Min
    • Min‑Woo Park
    • Mi‑Hyeong Park
    • Jin‑Hyub Paik
    • Sangho Choi
    • Imam Paryanto
    • Prasetyawan Yuniato
    • Sei‑Ryang Oh
    • Kyung‑Seop Ahn
    • Jae‑Won Lee
  • View Affiliations

  • Published online on: February 26, 2019     https://doi.org/10.3892/ijmm.2019.4110
  • Pages: 1830-1838
  • Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Physalis peruviana L. (PP) is well known for its various properties, including its antioxidant property. In our previous study, the protective effects of PP against cigarette smoke‑induced airway inflammation were confirmed. The purpose of the present study was to evaluate the anti‑inflammatory effect of PP against ovalbumin (OVA)‑induced airway inflammation. Treatment with PP inhibited the numbers of eosinophils and the levels of inflammatory cytokines, including interleukin (IL)‑4, IL‑5 and IL‑13, in the bronchoalveolar lavage fluid (BALF) of animal models with OVA‑induced allergic asthma. PP also significantly decreased the production of total immunoglobulin E in the serum. Lung sections stained with hematoxylin and eosin revealed that the influx of inflammatory cells was decreased in the lungs of mice treated with PP compared with cells in the OVA group. The increased expression levels of monocyte chemoattractant protein‑1 (MCP‑1) and T cell marker KEN‑5 were also reduced following PP treatment in the lung tissues compared with those in the OVA group. The PAS staining results showed that PP attenuated the overproduction of mucus in the lung. Additionally, western blot analysis revealed that PP significantly downregulated the activation of nuclear factor‑κB/p38 mitogen‑activated protein kinase/c‑Jun N‑terminal kinase, and upregulated the expression of heme oxgenase‑1 in the lungs. In an in vitro experiment, PP effectively reduced the levels of LPS‑stimulated MCP‑1 in a concentration‑dependent manner. Taken together, these results indicate that PP has considerable potential in the treatment of allergic asthma.
View Figures
View References

Related Articles

Journal Cover

April-2019
Volume 43 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park HA, Kwon OK, Ryu HW, Min JH, Park MW, Park MH, Paik JH, Choi S, Paryanto I, Yuniato P, Yuniato P, et al: Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules. Int J Mol Med 43: 1830-1838, 2019
APA
Park, H.A., Kwon, O., Ryu, H.W., Min, J., Park, M., Park, M. ... Lee, J. (2019). Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules. International Journal of Molecular Medicine, 43, 1830-1838. https://doi.org/10.3892/ijmm.2019.4110
MLA
Park, H. A., Kwon, O., Ryu, H. W., Min, J., Park, M., Park, M., Paik, J., Choi, S., Paryanto, I., Yuniato, P., Oh, S., Ahn, K., Lee, J."Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules". International Journal of Molecular Medicine 43.4 (2019): 1830-1838.
Chicago
Park, H. A., Kwon, O., Ryu, H. W., Min, J., Park, M., Park, M., Paik, J., Choi, S., Paryanto, I., Yuniato, P., Oh, S., Ahn, K., Lee, J."Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules". International Journal of Molecular Medicine 43, no. 4 (2019): 1830-1838. https://doi.org/10.3892/ijmm.2019.4110